University of Utah

University of Utah was paid $221.14M by Medicaid between Jan 2018 and Dec 2024, across 891 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 20% of everything it billed.

33Billing provider infoUNIVERSITY OF UTAH
SALT LAKE CITY, UT 84132

33aNPI1588656870assigned 08/22/2005

33bProvider typeDental Clinic/Center

28Total paid$221.14M

24GClaims4,831,388

24DCodes billed891

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Dental Clinic/Center providers in Utah

Rank by total paid#1 of 37

Median peer was paid$90K

This provider vs. median2,453×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	712,643	$26.79M
2019	750,766	$30.50M
2020	805,368	$37.80M
2021	1,113,457	$54.25M
2022	1,030,378	$54.91M
2023	245,735	$9.99M
2024incomplete	173,041	$6.90M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	20%	894,326	705,845	$43.60M
8888888	Internal/system code - not a standard HCPCS code	19%	175,319	59,760	$42.78M
J3490	Unclassified drugs	7.2%	165,489	64,129	$15.85M
36415	Collection of venous blood by venipuncture	6.2%	190,874	162,291	$13.73M
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	3.0%	70,578	60,484	$6.57M
J8499	Prescription drug, oral, non chemotherapeutic, nos	2.8%	102,204	29,882	$6.21M
J1100	Injection, dexamethasone sodium phosphate, 1 mg	2.2%	19,430	15,582	$4.92M
J0690	Injection, cefazolin sodium, 500 mg	2.1%	10,187	7,893	$4.74M
J2704	Injection, propofol, 10 mg	1.5%	16,344	11,823	$3.39M
J1885	Injection, ketorolac tromethamine, per 15 mg	1.5%	22,441	18,515	$3.24M
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	1.3%	22,337	19,521	$2.90M
J2250	Injection, midazolam hydrochloride, per 1 mg	1.3%	15,494	13,003	$2.85M

879 more codes

A9576	Injection, gadoteridol, (prohance multipack), per ml	1.2%	7,161	$2.76M
A9270	Non-covered item or service	1.2%	18,962	$2.61M
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	1.1%	2,786	$2.39M
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	31,557	$1.74M
36416		<1%	32,018	$1.66M
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	3,751	$1.63M
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	5,566	$1.60M
99283	Emergency room visit (moderate)	<1%	30,405	$1.38M
J1170	Injection, hydromorphone, up to 4 mg	<1%	9,403	$1.27M
A0431	Ambulance service, conventional air services, transport, one way (rotary wing)	<1%	493	$1.14M
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	4,871	$1.12M
V2020	Frames, purchases	<1%	10,883	$1.04M
J2270	Injection, morphine sulfate, up to 10 mg	<1%	6,566	$1.03M
80053	Comprehensive metabolic panel	<1%	135,186	$989K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	1,048	$988K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	28,697	$985K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	2,092	$982K
99284	Emergency room visit (serious)	<1%	39,026	$871K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	3,498	$859K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	5,321	$823K
81002		<1%	38,809	$813K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	22,656	$810K
82330		<1%	13,950	$802K
J8540	Dexamethasone, oral, 0.25 mg	<1%	2,006	$770K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	2,018	$764K
87088		<1%	24,329	$761K
80305		<1%	9,921	$760K
J2060	Injection, lorazepam, 2 mg	<1%	3,842	$744K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	2,911	$718K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	12,654	$706K
71046	Radiologic examination, chest; 2 views	<1%	20,498	$668K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	7,087	$629K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	6,960	$622K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	28,482	$618K
J1453	Injection, fosaprepitant, 1 mg	<1%	791	$599K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	1,245	$578K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	980	$560K
81025		<1%	27,094	$552K
A0436	Rotary wing air mileage, per statute mile	<1%	488	$536K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	9,873	$514K
J1790	Injection, droperidol, up to 5 mg	<1%	2,235	$512K
77336		<1%	2,053	$502K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	18,164	$495K
J0475	Injection, baclofen, 10 mg	<1%	2,593	$446K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	2,126	$434K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	23,275	$388K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	2,356	$377K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	1,045	$371K
90686		<1%	42,392	$370K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	559	$366K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	12,735	$346K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	4,305	$335K
95811		<1%	657	$335K
J3489	Injection, zoledronic acid, 1 mg	<1%	392	$322K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	2,241	$317K
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	4,008	$313K
64615		<1%	1,382	$308K
76830	Ultrasound, transvaginal	<1%	3,083	$303K
C9399	Unclassified drugs or biologicals	<1%	6,896	$300K
73610		<1%	5,804	$291K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	3,863	$290K
73630		<1%	7,615	$288K
86850		<1%	10,109	$283K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	4,713	$283K
73562		<1%	6,275	$282K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	4,604	$270K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,629	$267K
80076		<1%	8,547	$262K
J1815	Injection, insulin, per 5 units	<1%	3,077	$258K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,820	$253K
77386		<1%	1,370	$247K
83986		<1%	2,758	$245K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,026	$242K
77063	Screening digital breast tomosynthesis, bilateral	<1%	3,609	$238K
87081		<1%	3,987	$238K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	3,065	$236K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,400	$234K
0001A		<1%	11,626	$233K
87653		<1%	3,046	$227K
87480		<1%	5,550	$226K
87086	Culture, bacterial; quantitative colony count, urine	<1%	7,895	$222K
73030		<1%	5,708	$219K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	3,020	$217K
87070		<1%	5,738	$210K
A9152	Single vitamin/mineral/trace element, oral, per dose, not otherwise specified	<1%	1,549	$210K
73110		<1%	4,640	$208K
97161		<1%	3,709	$198K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	33,143	$198K
59025	Fetal non-stress test	<1%	7,107	$191K
73130		<1%	5,479	$191K
99173		<1%	8,642	$180K
72141		<1%	1,368	$179K
72100		<1%	4,964	$177K
80048	Basic metabolic panel (calcium, ionized)	<1%	37,256	$176K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,253	$175K
72110		<1%	2,942	$174K
J0461	Injection, atropine sulfate, 0.01 mg	<1%	127	$169K
A9153	Multiple vitamins, with or without minerals and trace elements, oral, per dose, not otherwise specified	<1%	1,287	$162K
A6257	Transparent film, sterile, 16 sq. in. or less, each dressing	<1%	6,209	$160K
95885		<1%	871	$158K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	5,057	$157K
76801		<1%	3,043	$156K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	3,253	$153K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	2,026	$151K
95886		<1%	1,056	$149K
97162		<1%	2,963	$147K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	5,112	$144K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	462	$142K
77300		<1%	442	$141K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	265	$134K
J1630	Injection, haloperidol, up to 5 mg	<1%	2,098	$129K
73560		<1%	4,213	$128K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	13,443	$128K
94010		<1%	2,756	$125K
73140		<1%	2,093	$125K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	193	$124K
64642		<1%	275	$123K
70450	Computed tomography, head or brain; without contrast material	<1%	5,619	$121K
J0572	Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine	<1%	508	$121K
73502		<1%	3,588	$120K
17110		<1%	2,245	$120K
72040		<1%	2,465	$118K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	390	$118K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	765	$116K
72050		<1%	1,741	$115K
99285	Emergency room visit (most serious)	<1%	13,740	$113K
77334		<1%	897	$111K
81001		<1%	45,102	$111K
77062		<1%	1,138	$111K
G0008	Administration of influenza virus vaccine	<1%	52,904	$109K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	2,768	$108K
87631		<1%	936	$107K
87077		<1%	4,276	$105K
31231		<1%	1,926	$104K
94060		<1%	885	$102K
82962		<1%	25,206	$101K
77412		<1%	1,541	$100K
0002A		<1%	4,078	$98K
71250		<1%	1,992	$97K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	211	$97K
J0574	Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine	<1%	423	$94K
73080		<1%	1,596	$91K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	206	$91K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	457	$90K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	1,702	$89K
93356		<1%	597	$84K
83013		<1%	2,330	$84K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	45,397	$82K
J1756	Injection, iron sucrose, 1 mg	<1%	1,604	$81K
76376		<1%	652	$81K
69210		<1%	1,684	$79K
74018		<1%	2,804	$78K
76536		<1%	1,251	$78K
77080		<1%	919	$77K
85610		<1%	27,748	$77K
J0178	Injection, aflibercept, 1 mg	<1%	1,590	$73K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	4,985	$72K
90651		<1%	8,020	$72K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	24,933	$71K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	152,007	$69K
67028	Intravitreal injection of a pharmacologic agent	<1%	3,395	$69K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	4,401	$67K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	4,431	$67K
73590		<1%	2,152	$66K
76770		<1%	1,385	$65K
90648		<1%	16,480	$64K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	3,621	$64K
72072		<1%	1,778	$64K
93321		<1%	2,250	$63K
72082		<1%	1,308	$62K
88142		<1%	7,107	$60K
73221		<1%	469	$60K
91200		<1%	1,048	$60K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	10,247	$60K
93971		<1%	2,682	$60K
96375	Therapeutic injection; each additional sequential IV push	<1%	22,195	$60K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,184	$58K
87340		<1%	10,180	$55K
71045	Radiologic examination, chest; single view	<1%	9,492	$55K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	659	$54K
90633		<1%	8,505	$53K
92557		<1%	1,644	$53K
0053A		<1%	2,398	$53K
70486		<1%	1,169	$52K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	2,070	$51K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	200	$51K
76642		<1%	2,020	$50K
73090		<1%	1,498	$49K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	9,233	$49K
96402		<1%	516	$48K
77280		<1%	94	$47K
92083		<1%	2,818	$47K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	993	$47K
J1250	Injection, dobutamine hydrochloride, per 250 mg	<1%	356	$47K
96361	Intravenous infusion, hydration; each additional hour	<1%	20,542	$47K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	9,366	$44K
J1071	Injection, testosterone cypionate, 1 mg	<1%	949	$43K
87210		<1%	3,572	$43K
77295		<1%	29	$43K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	7,498	$42K
95806		<1%	453	$40K
77290		<1%	104	$40K
0071A		<1%	1,404	$39K
T1015	A visit at a community health center or clinic (one all-in rate)	<1%	4,035	$39K
88304		<1%	867	$39K
69209		<1%	788	$39K
97165		<1%	651	$39K
J3480	Injection, potassium chloride, per 2 meq	<1%	625	$39K
0003A		<1%	1,631	$38K
82043		<1%	7,407	$37K
73600		<1%	677	$36K
77301		<1%	52	$36K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	29,919	$36K
74019		<1%	1,362	$35K
V2103	Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	<1%	6,041	$35K
86832		<1%	442	$35K
82274		<1%	1,093	$34K
76882		<1%	1,002	$34K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	3,844	$34K
J3411	Injection, thiamine hcl, 100 mg	<1%	489	$34K
73564		<1%	543	$33K
20610		<1%	4,744	$32K
12001		<1%	921	$32K
82565		<1%	7,453	$32K
71101		<1%	629	$32K
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	639	$31K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	60,130	$31K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	515	$30K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	565	$30K
31575		<1%	827	$29K
0072A		<1%	820	$29K
73552		<1%	1,181	$29K
11981		<1%	673	$29K
92558		<1%	348	$28K
73660		<1%	534	$28K
20611		<1%	2,202	$27K
83993		<1%	784	$27K
90685		<1%	3,001	$27K
92136		<1%	974	$27K
G0009	Administration of pneumococcal vaccine	<1%	22,706	$27K
92550		<1%	511	$27K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,405	$27K
17000		<1%	860	$26K
95812		<1%	167	$26K
10060		<1%	1,355	$26K
93970		<1%	519	$26K
J0897	Injection, denosumab, 1 mg	<1%	66	$26K
97163		<1%	400	$26K
91320		<1%	474	$26K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	3,487	$25K
93308		<1%	1,367	$25K
93296		<1%	1,441	$25K
90688		<1%	5,024	$25K
78815	Positron emission tomography (PET) for limited area imaging	<1%	927	$25K
90715		<1%	12,922	$25K
84156		<1%	6,899	$25K
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	39	$24K
97116		<1%	1,604	$24K
51798		<1%	4,397	$24K
97166		<1%	481	$24K
J1644	Injection, heparin sodium, per 1000 units	<1%	3,836	$24K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	2,607	$23K
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,792	$23K
A0430	Ambulance service, conventional air services, transport, one way (fixed wing)	<1%	22	$22K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	4,670	$22K
87045		<1%	695	$22K
83036	Hemoglobin; glycosylated (A1C)	<1%	66,210	$22K
72170		<1%	1,472	$21K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	36,399	$21K
76000		<1%	1,874	$21K
0052A		<1%	800	$20K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	7,846	$20K
93923		<1%	427	$20K
A0435	Fixed wing air mileage, per statute mile	<1%	22	$20K
51705		<1%	754	$20K
93017		<1%	626	$20K
96158		<1%	691	$20K
78264		<1%	79	$19K
82731		<1%	142	$19K
0054A		<1%	1,064	$19K
76870		<1%	366	$19K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	132	$18K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,634	$17K
84484		<1%	14,830	$17K
73521		<1%	419	$17K
80061	Lipid panel	<1%	34,911	$17K
73070		<1%	753	$17K
87040		<1%	3,779	$16K
V2784	Lens, polycarbonate or equal, any index, per lens	<1%	3,874	$16K
73000		<1%	280	$16K
90670		<1%	17,792	$16K
88720		<1%	518	$15K
99188		<1%	683	$15K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	518	$15K
88184		<1%	1,028	$15K
82805		<1%	13,670	$15K
J7050	Infusion, normal saline solution, 250 cc	<1%	738	$15K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	6,129	$15K
92134		<1%	6,522	$15K
82728		<1%	19,022	$15K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	3,790	$14K
A4344	Indwelling catheter, foley type, two-way, all silicone or polyurethane, each	<1%	121	$14K
90480		<1%	841	$14K
Q3014	Telehealth originating site facility fee	<1%	11,671	$14K
C9257	Injection, bevacizumab, 0.25 mg	<1%	1,467	$14K
90696		<1%	3,496	$14K
99201		<1%	1,356	$14K
87632		<1%	266	$14K
86900		<1%	10,986	$14K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	416	$14K
77061		<1%	172	$14K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	20,275	$13K
86769		<1%	474	$13K
0051A		<1%	644	$13K
87507		<1%	407	$13K
86592		<1%	11,838	$13K
72146		<1%	111	$13K
54150		<1%	377	$13K
52000		<1%	500	$13K
93325		<1%	2,355	$12K
73700		<1%	200	$12K
84132		<1%	12,996	$12K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	1,169	$12K
85651		<1%	11,323	$12K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	5,386	$12K
76942		<1%	2,426	$12K
J9271	Injection, pembrolizumab, 1 mg	<1%	220	$12K
11976		<1%	82	$12K
83550		<1%	10,746	$11K
73060		<1%	535	$11K
J1940	Injection, furosemide, up to 20 mg	<1%	46	$11K
84702		<1%	4,391	$11K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	3,613	$11K
84443	Thyroid stimulating hormone (TSH)	<1%	49,815	$11K
97535	Self-care/home management training, each 15 minutes	<1%	769	$11K
92250		<1%	1,655	$10K
88307		<1%	1,305	$10K
88342		<1%	2,590	$10K
76937		<1%	5,121	$10K
90677		<1%	2,024	$10K
83540		<1%	12,779	$10K
20553		<1%	1,096	$10K
J3360	Injection, diazepam, up to 5 mg	<1%	79	$10K
31720		<1%	182	$10K
96159		<1%	618	$10K
96401		<1%	18	$9K
90750		<1%	65	$9K
85027		<1%	22,682	$9K
58301		<1%	775	$9K
90732		<1%	3,481	$9K
80069		<1%	4,838	$9K
96367		<1%	2,237	$9K
58300		<1%	1,610	$9K
87338		<1%	660	$9K
77077		<1%	1,151	$9K
A4565	Slings	<1%	229	$9K
11721		<1%	769	$9K
82247		<1%	2,175	$9K
82570		<1%	8,089	$9K
92552		<1%	117	$9K
87205		<1%	5,799	$9K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	112	$8K
74183		<1%	644	$8K
92133		<1%	2,841	$8K
0073A		<1%	224	$8K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	556	$8K
G0378	Hospital observation service, per hour	<1%	5,527	$8K
64643		<1%	92	$8K
16020		<1%	885	$8K
80164		<1%	2,075	$8K
71271		<1%	108	$8K
62370		<1%	1,875	$8K
72131		<1%	324	$7K
80050	General health panel	<1%	2,343	$7K
0399T		<1%	81	$7K
90734		<1%	5,670	$7K
86480		<1%	2,914	$7K
J0485	Injection, belatacept, 1 mg	<1%	197	$7K
86140		<1%	13,898	$7K
81015		<1%	1,587	$7K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	4,098	$7K
V2104	Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens	<1%	2,040	$6K
80178		<1%	3,553	$6K
82670		<1%	2,024	$6K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	214	$6K
87186		<1%	10,931	$6K
87536		<1%	5,269	$6K
87324		<1%	841	$6K
94760		<1%	118	$6K
93297		<1%	208	$6K
82550		<1%	3,026	$5K
83735		<1%	15,327	$5K
90707		<1%	3,937	$5K
87147		<1%	4,943	$5K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	279	$5K
86833		<1%	387	$5K
87102		<1%	747	$5K
92551		<1%	72	$5K
90656		<1%	2,091	$5K
90680		<1%	11,225	$5K
87799		<1%	1,449	$5K
51703		<1%	336	$5K
12011		<1%	174	$5K
82607		<1%	16,023	$5K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	174	$5K
86235		<1%	1,737	$5K
A9698	Non-radioactive contrast imaging material, not otherwise classified, per study	<1%	869	$5K
90700		<1%	3,907	$5K
85379		<1%	4,050	$5K
52310		<1%	52	$5K
93270		<1%	735	$5K
90472	Immunization administration, each additional vaccine (list separately)	<1%	39,173	$5K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	3,168	$5K
87529		<1%	313	$4K
88173		<1%	70	$4K
93225		<1%	304	$4K
82784		<1%	4,860	$4K
83690		<1%	12,889	$4K
70491		<1%	961	$4K
87497		<1%	1,881	$4K
83516		<1%	5,141	$4K
90716		<1%	3,835	$4K
80197		<1%	4,753	$4K
86803		<1%	15,938	$4K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	34,475	$4K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	17,036	$4K
93660		<1%	14	$4K
73650		<1%	83	$4K
94762		<1%	45	$4K
V2100	Sphere, single vision, plano to plus or minus 4.00, per lens	<1%	2,511	$4K
87177		<1%	249	$4K
29125		<1%	364	$4K
87075		<1%	1,473	$4K
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	5,521	$4K
84100		<1%	9,554	$4K
82040		<1%	826	$4K
86304		<1%	1,073	$4K
81513		<1%	4,397	$4K
83880		<1%	6,346	$4K
96376		<1%	8,990	$4K
97542		<1%	58	$4K
76510		<1%	40	$4K
83655		<1%	2,143	$3K
72220		<1%	90	$3K
66982		<1%	264	$3K
84439		<1%	10,258	$3K
83520		<1%	1,760	$3K
82340		<1%	60	$3K
87015		<1%	22	$3K
82103		<1%	261	$3K
90636		<1%	520	$3K
86901		<1%	10,993	$3K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	1,453	$3K
83615		<1%	8,660	$3K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	1,007	$3K
85018		<1%	3,320	$3K
86317		<1%	3,473	$3K
82653		<1%	26	$3K
0031A		<1%	449	$3K
97763		<1%	67	$3K
73620		<1%	276	$3K
83605		<1%	4,337	$3K
84165		<1%	2,525	$3K
92567		<1%	944	$3K
95813		<1%	12	$3K
11100		<1%	268	$3K
82378		<1%	2,030	$3K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	<1%	626	$3K
85007		<1%	1,332	$3K
94761		<1%	101	$3K
70496		<1%	1,131	$3K
11720		<1%	449	$3K
84703		<1%	2,141	$2K
11750		<1%	54	$2K
90710		<1%	4,115	$2K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	604	$2K
94727		<1%	2,662	$2K
87522	Neg quan hep c or qual rna	<1%	3,363	$2K
C1729	Catheter, drainage	<1%	705	$2K
80156		<1%	231	$2K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	4,458	$2K
85045		<1%	1,138	$2K
84153		<1%	3,162	$2K
36000		<1%	3,655	$2K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	8,402	$2K
82310		<1%	1,307	$2K
81511		<1%	819	$2K
82533		<1%	833	$2K
66821		<1%	16	$2K
93976		<1%	517	$2K
86923		<1%	1,179	$2K
87493		<1%	389	$2K
C1769	Guide wire	<1%	2,995	$2K
70498		<1%	979	$2K
36430		<1%	809	$2K
99153	Mod sedat endo service >5yrs	<1%	7,173	$2K
99152		<1%	5,901	$2K
46600		<1%	167	$2K
82105		<1%	2,500	$2K
0082A		<1%	375	$2K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	29	$2K
86003		<1%	344	$2K
64493		<1%	700	$2K
96152		<1%	50	$2K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,879	$2K
C8930	Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision	<1%	152	$2K
90713		<1%	614	$2K
86334		<1%	1,937	$2K
92025		<1%	85	$2K
64483		<1%	1,442	$2K
90687		<1%	526	$2K
43235		<1%	890	$2K
86361		<1%	3,127	$2K
77066	Tomosynthesis, mammo	<1%	1,243	$2K
11104		<1%	531	$2K
64450		<1%	727	$2K
80177		<1%	475	$2K
95117		<1%	637	$2K
11730		<1%	27	$2K
88185		<1%	1,368	$2K
71275	Computed tomographic angiography, chest, with contrast material	<1%	586	$2K
90723		<1%	12,882	$2K
86160		<1%	1,634	$2K
Q9961	High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml	<1%	264	$2K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	208	$2K
77081		<1%	471	$2K
86706		<1%	986	$2K
83970		<1%	4,580	$1K
97802		<1%	1,112	$1K
82948		<1%	180	$1K
96156		<1%	51	$1K
77065	Tomosynthesis, mammo	<1%	295	$1K
Q0114	Fern test	<1%	1,991	$1K
86038		<1%	3,208	$1K
29130		<1%	98	$1K
84295		<1%	12,823	$1K
A4648	Tissue marker, implantable, any type, each	<1%	16	$1K
80143		<1%	2,281	$1K
97803		<1%	1,305	$1K
82950		<1%	3,171	$1K
82977		<1%	2,791	$1K
77002		<1%	468	$1K
96415		<1%	3,537	$1K
76881		<1%	15	$1K
84160		<1%	632	$1K
80074		<1%	1,200	$1K
95970		<1%	315	$1K
84134		<1%	2,002	$1K
94729		<1%	2,686	$1K
11102		<1%	681	$1K
51700		<1%	136	$1K
96416		<1%	448	$1K
82746		<1%	7,429	$1K
86922		<1%	119	$1K
82785		<1%	540	$1K
92285		<1%	617	$1K
93351		<1%	727	$1K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	14	$1K
93990		<1%	276	$1K
72128		<1%	121	$978.70
12002		<1%	99	$945.52
90744		<1%	423	$944.30
85014		<1%	1,660	$940.15
82077		<1%	2,763	$935.40
96164		<1%	97	$925.48
74178		<1%	190	$920.15
L4360	Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	15	$916.38
86703		<1%	540	$902.58
82525		<1%	1,608	$902.20
88313		<1%	492	$899.10
72156		<1%	611	$886.95
95910		<1%	112	$876.08
11719		<1%	79	$871.54
88240		<1%	1,112	$853.02
86255		<1%	440	$849.12
84403		<1%	4,420	$842.31
0081A		<1%	760	$826.67
85730		<1%	6,098	$825.49
J7507	Tacrolimus, immediate release, oral, 1 mg	<1%	38	$825.41
83883		<1%	553	$816.24
83861		<1%	1,827	$812.78
86765		<1%	547	$811.03
84146		<1%	2,299	$786.79
86704		<1%	2,747	$780.32
49083		<1%	30	$775.80
74160		<1%	48	$744.43
90662		<1%	470	$696.72
94618		<1%	40	$690.13
89051		<1%	1,357	$672.55
93288		<1%	26	$661.76
86300		<1%	352	$651.03
84270		<1%	2,253	$639.02
90739		<1%	118	$612.66
51741		<1%	819	$611.36
84550		<1%	3,048	$600.28
94660		<1%	142	$583.71
87305		<1%	212	$549.87
58100		<1%	109	$549.45
95911		<1%	55	$546.66
J7325	Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg	<1%	18	$540.83
74230		<1%	84	$529.50
86141		<1%	2,178	$518.81
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	259	$518.51
38222		<1%	42	$518.22
90694		<1%	580	$514.97
86200		<1%	1,912	$509.51
95908		<1%	105	$506.39
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	292	$504.96
90746		<1%	50	$500.38
73200		<1%	14	$499.96
86762		<1%	3,983	$498.15
93242		<1%	73	$477.86
J2785	Injection, regadenoson, 0.1 mg	<1%	266	$467.50
86256		<1%	753	$464.09
87427		<1%	765	$460.42
86308		<1%	69	$450.35
87481		<1%	4,306	$448.05
72080		<1%	13	$447.32
83001		<1%	2,269	$445.40
87449		<1%	939	$445.28
64447		<1%	206	$442.75
87902		<1%	539	$432.47
86580		<1%	13	$420.61
36591		<1%	4,434	$417.02
94799		<1%	99	$408.16
86376		<1%	967	$407.29
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,562	$404.50
86039		<1%	1,469	$402.99
82150		<1%	1,050	$400.62
88341		<1%	61	$398.99
84425		<1%	1,960	$396.13
93280		<1%	142	$383.62
87660		<1%	5,559	$379.11
96165		<1%	98	$366.38
86309		<1%	157	$362.80
92553		<1%	12	$358.75
82384		<1%	45	$358.23
J2280	Injection, moxifloxacin, 100 mg	<1%	819	$354.37
90935	Hemodialysis procedure with single evaluation by a physician	<1%	190	$352.98
62368		<1%	30	$340.24
93289		<1%	14	$326.52
87046		<1%	754	$316.59
0124A		<1%	2,976	$308.55
95971		<1%	91	$300.67
84402		<1%	1,582	$294.20
90714		<1%	66	$289.25
87517		<1%	436	$283.02
64494		<1%	660	$282.56
M0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring	<1%	53	$282.09
70544		<1%	16	$275.52
96138		<1%	53	$273.61
86708		<1%	1,804	$273.08
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	826	$263.44
88312		<1%	717	$259.95
86694		<1%	367	$255.52
J9190	Injection, fluorouracil, 500 mg	<1%	720	$252.29
92235		<1%	29	$244.31
84450		<1%	1,778	$237.15
86146		<1%	183	$236.00
Q0221	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg	<1%	16	$235.30
86147		<1%	285	$228.86
87252		<1%	13	$223.24
G0010	Administration of hepatitis b vaccine	<1%	1,427	$222.92
84466		<1%	1,587	$222.05
80175		<1%	526	$220.17
72157		<1%	235	$220.10
82390		<1%	459	$217.35
V2025	Deluxe frame	<1%	563	$213.31
82140		<1%	582	$204.03
90474		<1%	11,136	$192.84
86431		<1%	2,694	$186.98
82810		<1%	150	$182.02
90632		<1%	26	$180.06
84590		<1%	1,131	$179.86
82248		<1%	1,155	$179.63
84155		<1%	1,870	$179.61
77001		<1%	204	$177.40
84207		<1%	444	$177.40
86665		<1%	247	$170.02
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	301	$167.87
87510		<1%	5,549	$161.96
84255		<1%	875	$154.77
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	<1%	5,975	$154.75
83021		<1%	110	$154.62
A6258	Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing	<1%	107	$151.05
17003		<1%	270	$150.90
0083A		<1%	98	$150.28
36592		<1%	589	$145.82
97164		<1%	28	$144.41
88360		<1%	14	$143.07
84630		<1%	1,486	$130.30
87206		<1%	43	$126.94
83519		<1%	23	$123.54
V2107	Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00 sphere, .12 to 2.00d cylinder, per lens	<1%	254	$121.43
82951		<1%	163	$120.16
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	52	$118.12
90674		<1%	14	$117.66
91307		<1%	316	$116.19
20605		<1%	13	$115.18
76775		<1%	27	$114.94
0296T		<1%	28	$113.69
82652		<1%	40	$110.32
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	251	$106.74
86036		<1%	39	$104.43
76377		<1%	15	$100.03
83002		<1%	1,516	$99.08
99454		<1%	47	$98.66
80179		<1%	2,156	$97.79
86787		<1%	299	$97.22
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	183	$97.00
83721		<1%	1,910	$95.96
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	137	$88.42
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	6,087	$86.58
84460		<1%	1,878	$84.49
83921		<1%	833	$76.36
86644		<1%	32	$71.36
86800		<1%	575	$70.72
77338		<1%	52	$68.90
86335		<1%	85	$60.55
82947		<1%	2,716	$59.64
82610		<1%	500	$58.36
83525		<1%	1,357	$58.01
90653		<1%	13	$57.76
62369		<1%	265	$55.44
83521		<1%	418	$53.40
C1892	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away	<1%	470	$53.30
86301		<1%	323	$46.20
86663		<1%	13	$45.00
72158		<1%	258	$40.34
86780		<1%	514	$38.56
L0140	Cervical, semi-rigid, adjustable (plastic collar)	<1%	33	$38.55
99408		<1%	179	$38.33
84480		<1%	343	$31.52
82945		<1%	165	$28.62
87116		<1%	29	$27.69
84157		<1%	169	$26.73
82365		<1%	12	$24.71
84481		<1%	1,081	$23.39
86880		<1%	78	$21.85
96417		<1%	1,966	$21.59
85613		<1%	232	$21.30
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	107	$16.60
84133		<1%	232	$15.17
86735		<1%	43	$14.50
87209		<1%	244	$14.38
86707		<1%	56	$12.85
87350		<1%	94	$12.81
86364		<1%	723	$10.76
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	<1%	53	$10.66
20560		<1%	468	$9.39
92060		<1%	44	$8.59
86593		<1%	521	$7.83
95974		<1%	45	$7.45
84145		<1%	216	$7.32
20561		<1%	566	$6.31
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	44	$5.78
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	24	$5.49
80235		<1%	15	$3.17
83930		<1%	81	$0.44
S9455	Diabetic management program, group session	<1%	104	$0.09
64484		0%	92	$0.00
V2632	Posterior chamber intraocular lens	0%	1,945	$0.00
86258		0%	139	$0.00
84154		0%	523	$0.00
41899	Unlisted procedure, dentoalveolar structures	0%	685	$0.00
84432		0%	28	$0.00
86812		0%	13	$0.00
74174		0%	83	$0.00
V2105	Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 4.25 to 6.00d cylinder, per lens	0%	142	$0.00
20550		0%	805	$0.00
64405		0%	223	$0.00
64635		0%	105	$0.00
J9045	Injection, carboplatin, 50 mg	0%	175	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	107	$0.00
91065		0%	143	$0.00
G0103	Prostate cancer screening; prostate specific antigen test (psa)	0%	87	$0.00
84144		0%	92	$0.00
86381		0%	128	$0.00
82952		0%	151	$0.00
J2175	Injection, meperidine hydrochloride, per 100 mg	0%	167	$0.00
97804		0%	68	$0.00
96040		0%	191	$0.00
99156		0%	80	$0.00
81599		0%	12	$0.00
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	0%	75	$0.00
84446		0%	49	$0.00
86664		0%	41	$0.00
96368		0%	111	$0.00
74420		0%	124	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	106	$0.00
96411		0%	154	$0.00
86695		0%	76	$0.00
70543		0%	13	$0.00
81332		0%	13	$0.00
11900		0%	77	$0.00
86870		0%	126	$0.00
90620		0%	14	$0.00
88311		0%	96	$0.00
84300		0%	120	$0.00
96110	Developmental screening, with scoring and documentation, per standardized instrument	0%	15	$0.00
96139		0%	41	$0.00
86225		0%	140	$0.00
73720		0%	18	$0.00
86341		0%	20	$0.00
V2744	Tint, photochromatic, per lens	0%	13	$0.00
57454		0%	69	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	46	$0.00
52287		0%	29	$0.00
C1726	Catheter, balloon dilatation, non-vascular	0%	96	$0.00
A4615	Cannula, nasal	0%	27	$0.00
V2755	U-v lens, per lens	0%	12	$0.00
J3471	Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)	0%	51	$0.00
J1097	Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml	0%	33	$0.00
J8501	Aprepitant, oral, 5 mg	0%	14	$0.00
82575		0%	14	$0.00
P9612	Catheterization for collection of specimen, single patient, all places of service	0%	18	$0.00
87184		0%	28	$0.00
88108		0%	14	$0.00
82024		0%	36	$0.00
76820		0%	15	$0.00
77470		0%	15	$0.00
97597		0%	43	$0.00
82436		0%	26	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	18	$0.00
87506		0%	20	$0.00
64445		0%	22	$0.00
M0221	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency	0%	15	$0.00
J0185	Injection, aprepitant, 1 mg	0%	24	$0.00
80354		0%	340	$0.00
J3473	Injection, hyaluronidase, recombinant, 1 usp unit	0%	252	$0.00
95873		0%	723	$0.00
99177		0%	798	$0.00
87899		0%	374	$0.00
J9035	Injection, bevacizumab, 10 mg	0%	91	$0.00
72197		0%	102	$0.00
82085		0%	55	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	291	$0.00
C1776	Joint device (implantable)	0%	616	$0.00
80169		0%	459	$0.00
74220		0%	27	$0.00
88237		0%	34	$0.00
86015		0%	54	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	395	$0.00
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	0%	12	$0.00
82595		0%	12	$0.00
20552		0%	58	$0.00
J9263	Injection, oxaliplatin, 0.5 mg	0%	21	$0.00
J0735	Injection, clonidine hydrochloride, 1 mg	0%	58	$0.00
86753		0%	220	$0.00
J1750	Injection, iron dextran, 50 mg	0%	495	$0.00
84305		0%	72	$0.00
G8989	Self care functional limitation, discharge status, at discharge from therapy or to end reporting	0%	13	$0.00
64636		0%	122	$0.00
J9206	Injection, irinotecan, 20 mg	0%	19	$0.00
82627		0%	80	$0.00
95909		0%	12	$0.00
95923		0%	37	$0.00
85060		0%	101	$0.00
V2750	Anti-reflective coating, per lens	0%	74	$0.00
95921		0%	14	$0.00
84166		0%	16	$0.00
90681		0%	29	$0.00
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	0%	46	$0.00
86682		0%	112	$0.00
A4306	Disposable drug delivery system, flow rate of less than 50 ml per hour	0%	111	$0.00
62323		0%	41	$0.00
91308		0%	21	$0.00
95874		0%	56	$0.00
86696		0%	78	$0.00
V2410	Variable asphericity lens, single vision, full field, glass or plastic, per lens	0%	13	$0.00
82042		0%	68	$0.00
84681		0%	30	$0.00
84445		0%	12	$0.00
36600		0%	42	$0.00
82747		0%	13	$0.00
99157		0%	48	$0.00
96549		0%	24	$0.00
J1095	Injection, dexamethasone 9 percent, intraocular, 1 microgram	0%	21	$0.00
43249		0%	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPARK, CHARLTON (CHIEF FINANCIAL OFFICER)

Same official

Other billing entities under PARK, CHARLTON

Full network →

Provider	Location	Paid
University of Utah	Salt Lake City, UT	$23.16M
University of Utah	Salt Lake City, UT	$2.06M
University of Utah	Salt Lake City, UT	$17K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.